Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ICP-248 |
| Trade Name | |
| Synonyms | ICP248|ICP 248 |
| Drug Descriptions |
ICP-248 inhibits BCL2, which potentially reduces tumor growth (J Clin Oncol 2025 43: 16_suppl, 7038). |
| DrugClasses | BCL2 inhibitor 29 |
| CAS Registry Number | NA |
| NCIT ID | C215084 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| ICP-248 | ICP-248 | 0 | 1 |
| ICP-248 + Obinutuzumab | ICP-248 Obinutuzumab | 0 | 1 |
| ICP-248 + Rituximab | ICP-248 Rituximab | 0 | 1 |